Consortium withdraws proposal to acquire Monash IVF
Key points
- Consortium comprising Genesis Capital and WHSP Holdings withdraws non-binding indicative proposal
- Proposal was to acquire 100% of Monash IVF shares at $0.80 per share
- Monash IVF will inform shareholders of any material developments in the future
Full summary
Monash IVF Group Limited (ASX:MVF) has received correspondence from the consortium comprising Genesis Capital Investment Management Pty Ltd ('Genesis Capital' or 'Genesis') and WHSP Holdings Pty Limited ('Soul Patts') (together, the 'Consortium') withdrawing the Consortium's non-binding indicative proposal to acquire 100% of the shares in Monash IVF at $0.80 per share by way of a Scheme of Arrangement ('Proposal'). The announcement comes further to the ASX release dated 24 November 2025, where Monash IVF had initially received the Consortium's non-binding indicative proposal. Monash IVF has stated that if there are any material developments in the future, the company will inform shareholders as required under its continuous disclosure obligations.
Summary generated by a large language model. Please interpret with care.